Clinical Trial Update: Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 dosimetry and biodistribution study of the radiotracer [18F]-Fludarabine in untreated lymphoid malignancies, including chronic lymphocytic leukemia and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma

Drugs mentioned

• 18F-Fludarabine (Fludarabine-18F)

Snippet

Sponsor: University Hospital, Caen | Conditions: Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients | Phase 1 | Status: COMPLETED